乳腺癌药物治疗与心肌损伤

Drug Therapy of Breast Cancer and Assosiated Myocardial Damage

目前全球乳腺癌发病率呈持续上升趋势,已成为当前社会广泛关注的大公共卫生事件.随着对乳腺癌治疗认识的不断深入,以及治疗理念的不断更新,乳腺癌的治疗进入了综合治疗时代.药物治疗是乳腺癌患者的综合治疗措施不可缺少的部分,它可有效提高生存率、降低复发率和死亡率.药物治疗虽有一定疗效,但药物治疗引起的心肌损伤程度也随着药物累积剂量的增加而增加.因此,不仅要关注乳腺癌的治疗,还要控制乳腺癌药物治疗引起的心肌损伤的风险.

The global breast cancer incidence rate is indeed rising,which had attract the social attention and become the public health event.Comprehensive treatment of breast cancer is becoming popular because of the in-depth understanding and concept upgrading about the breast cancer therapy.Drug therapy,which can raises survival rate,decrease the recurrence rate and reduce the mortality rate,is indispensable in comprehensive treatment of breast cancer.However,myocardial damage will be accumulated along with the increase of dosage of drug,even if the drug therapy works well.Therefore,we not only need to pay attention to breast cancer treatment,but also need to control the risk of myocardial damage caused by breast cancer drug treatment.